Arcus Biosciences Inc (RCUS)

Inventory turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	146,000	147,000	147,000	145,000	122,000	119,374	115,668	113,504	106,935	102,117	92,166	83,156	74,346	63,355	58,189	52,795	44,024	37,906	35,287	30,566
Inventory	US$ in thousands	—	—	—	—	—	-207,000	-80,000	-90,000	-172,000	0	0	—	-762,442	—	—	—	-7,169	—	—	—
Inventory turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $146,000K ÷ $—K
= —

Based on the provided data, it appears that Arcus Biosciences Inc has not disclosed its inventory turnover ratios for the periods listed from March 31, 2020, to December 31, 2024. This lack of information on inventory turnover makes it challenging to assess the efficiency of the company in managing its inventory levels and generating sales from its inventory.

Inventory turnover is a critical financial ratio that indicates how many times a company's inventory is sold and replaced over a specific period. A high inventory turnover ratio typically suggests that a company is effectively managing its inventory levels, while a low ratio may indicate overstocking or slow-moving inventory.

Without the specific inventory turnover figures for Arcus Biosciences Inc, it is not possible to evaluate the company's inventory management performance or compare it with industry benchmarks. Investors and analysts often use this ratio to assess a company's operational efficiency and supply chain management, so the absence of this data can limit the insights into Arcus Biosciences' financial health and operational performance in relation to its inventory management.